Viewing nowLipicure Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
IQUR Co., Ltd.

MFDS item code 201601761 · Approved 2016.03.23 · Insurance code 674400750
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia); prevention of cardiovascular disease
This medication is effective in reducing the risk of various cardiovascular diseases. It helps lower the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary artery disease and patients with type 2 diabetes. It also significantly reduces the risk of hospitalization due to vascular interventions, angina, and congestive heart failure. In patients with hyperlipidemia, it is used to lower total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels, while increasing good cholesterol levels (HDL-cholesterol). It particularly helps improve blood lipid levels in pediatric patients with familial hypercholesterolemia when used alongside dietary therapy. This medication is used to overall improve cardiovascular health and reduce the risk of related diseases.
Patients taking atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take the medicine at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, patients requiring greater LDL cholesterol reduction may start with 20 mg or 40 mg once daily (only when LDL cholesterol reduction of 45 % or greater is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Because the goal of treatment is to reduce LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age or older are generally similar to those in adult patients.
10 ~ 17 years: The recommended starting dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication poses a risk of muscle problems; thus, discontinue use immediately and consult a doctor if symptoms such as muscle pain or weakness occur. It should not be administered to those with an allergy to this medication or those with liver diseases or muscular disorders. Pregnant or breastfeeding women should not take this medication, and women of childbearing age must use appropriate contraception during its use. Patients with impaired liver function should exercise special caution when using this medication and should have regular liver function tests. This medication may interact with other drugs, so patients taking certain antibiotics, antifungals, antivirals, immunosuppressants, etc., must inform their doctor or pharmacist and exercise caution. Elderly patients or patients with reduced kidney function are at higher risk for muscle damage, requiring closer monitoring during use. During treatment, if symptoms such as muscle pain, fatigue, or fever occur, medical staff should be notified immediately. Children, especially those under 10 years old, should not take this medication, while adolescents over 10 years should only take it under a specialist's guidance. In case of overdose, there is no specific antidote, so one should go to the hospital immediately for treatment based on symptoms. Store this medication out of reach of children and ensure it is kept in its original container for safety. During treatment, closely monitor for symptoms of muscle abnormalities and signs of liver dysfunction, and notify a doctor if any abnormal symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air or moisture. It is best to maintain storage temperatures between 1 to 30 degrees Celsius.
White oval film-coated tablet
30 tablets, 100 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
IQUR Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.